BDH Industries Ltd (MBIND) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524828 | NSE: MBIND | Pharmaceuticals & Drugs | Small Cap

BDH Inds Share Price

370 -3.90 -1.04%
as on 05-Dec'25 12:16

BDH Industries Ltd (MBIND) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524828 | NSE: MBIND | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on BDH Inds

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

BDH Industries stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
22.09
Market Cap:
215.3 Cr.
52-wk low:
241
52-wk high:
523.8

Is BDH Industries Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of BDH Inds: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
BDH Industries Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 15.4%14.9%14.7%16.9%19.1%18.7%19.6%20.8%21%18.2%-
Value Creation
Index
0.10.10.10.20.40.30.40.50.50.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 46.143.74151.759.557.569.474.585.866.572
Sales YoY Gr.--5.3%-6.1%26%15.1%-3.4%20.8%7.3%15.3%-22.5%-
Adj EPS 5.65.86.58.410.311.11214.317.116.116.9
YoY Gr.-3.9%12.8%28.3%23%7.1%8.6%18.8%20.3%-6%-
BVPS (₹) 44.64851.656.963.772.282.192.7105.7117.1120.4
Adj Net
Profit
3.23.33.84.85.96.46.98.29.99.310
Cash Flow from Ops. 4.37.2-0.2-3.611.40.836.3-1.914.8-
Debt/CF from Ops. 2.21.2-51.5-3.60.810.90.80.8-4.70.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 4.2%2.3%-1.4%-22.5%
Adj EPS 12.5%9.3%10.3%-6%
BVPS11.3%12.9%12.6%10.9%
Share Price 13% 35.1% 34.5% 0.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
12.511.812.514.716.415.615.115.916.914.214.3
Op. Profit
Mgn %
8.91113.113.615.114.813.114.714.517.516.8
Net Profit
Mgn %
77.69.29.31011.1101111.513.913.6
Debt to
Equity
0.40.30.30.40.30.20.10.10.100
Working Cap
Days
126111132155146156154160175229166
Cash Conv.
Cycle
-18-34-44-13-4-6862129125

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - BDH Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 16.9 -
TTM Sales (₹ Cr.) 71.6 -
BVPS (₹.) 120.4 -
Reserves (₹ Cr.) 64 -
P/BV 3.11 -
PE 22.09 -
From the Market
52 Week Low / High (₹) 241.00 / 523.75
All Time Low / High (₹) 2.45 / 523.75
Market Cap (₹ Cr.) 215
Equity (₹ Cr.) 5.8
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of BDH Inds:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of BDH Inds - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of BDH Inds

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales46444152595769748667
Operating Expenses 42393645514960647355
Manufacturing Costs87799781088
Material Costs24232027313344445537
Employee Cost 5667767777
Other Costs 4323332323
Operating Profit 4557999111212
Operating Profit Margin (%) 8.9%11.0%13.1%13.5%15.1%14.8%13.1%14.7%14.5%17.5%
Other Income 2111111122
Interest 0001100000
Depreciation 1111111111
Exceptional Items 0000000000
Profit Before Tax 55578910111312
Tax 2212222333
Profit After Tax 33456678109
PAT Margin (%) 7.0%7.6%9.2%9.3%10.0%11.1%10.4%11.0%11.5%13.9%
Adjusted EPS (₹)5.65.86.58.410.311.112.614.317.116.1
Dividend Payout Ratio (%)36%35%34%33%24%27%29%28%26%28%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 27293134384349556269
Share Capital 6666666666
Reserves 21232528323743495663
Minority Interest0000000000
Debt98813992591
Long Term Debt0100000000
Short Term Debt98713992591
Trade Payables13141616161716192115
Others Liabilities 2322222212
Total Liabilities 52545766657169809387

Fixed Assets

Gross Block25353636363636363838
Accumulated Depreciation12121314151616171718
Net Fixed Assets 13232322212020192020
CWIP 4000000000
Investments 0000000000
Inventories5368557757
Trade Receivables88713111515172814
Cash Equivalents flag 20191717232319262531
Others Assets 2146579111414
Total Assets 52545766657169809387

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 47-0-411136-215
PBT 55578910111312
Adjustment 1-0001-0-0-0-1-1
Changes in Working Capital 04-4-95-5-3-2-116
Tax Paid -2-2-1-2-2-2-3-3-3-3
Cash Flow From Investing Activity -5-5011110-02
Capex -5-7-0-0-0-01-0-2-0
Net Investments 0000000-000
Others 0111111122
Cash Flow From Financing Activity -1-3-33-6-2-801-10
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 01-1-0000000
Interest Paid 0-0-0-1-1-0-0-0-0-0
Dividend Paid -1-1-1-1-2-1-2-2-2-3
Others 1-2-05-4-1-634-8
Net Cash Flow -1-1-206-0-47-16

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)13.412.5113.1315.4617.1116.2616.2716.3117.2814.46
ROCE (%)15.3914.914.7416.9419.1418.7419.6120.8421.0318.18
Asset Turnover Ratio0.90.840.740.840.910.840.9910.990.74
PAT to CFO Conversion(x)1.332.33-0-0.81.830.170.430.75-0.21.67
Working Capital Days
Receivable Days706567707283787696117
Inventory Days41324149393332342634
Payable Days213219271221187183141148132179

BDH Industries Ltd Stock News

BDH Industries Ltd FAQs

The current trading price of BDH Inds on 05-Dec-2025 12:16 is ₹370.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of BDH Inds stood at ₹215.3.
The latest P/E ratio of BDH Inds as of 04-Dec-2025 is 22.09.
The latest P/B ratio of BDH Inds as of 04-Dec-2025 is 3.11.
The 52-week high of BDH Inds is ₹523.8 and the 52-week low is ₹241.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of BDH Inds is ₹71.60 ( Cr.) .

About BDH Industries Ltd

BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.

BDH Industries is engaged in the manufacture and marketing of formulations and bulk drugs. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.

BDH exports a wide range of finished pharmaceutical formulations and bulk drugs to leading organizations in several countries, including Australia, Bolivia, Denmark, Dominican Republic, Germany, Ghana, Japan, Kenya, Madagascar, Malaysia, Mozambique, Netherlands, Niger, Nigeria, Papua New Guinea, Yemen, Singapore, Sri Lanka, Sudan, West Indies, Zambia, Zimbabwe, etc.

Products offered by the Company:

Some of its therapeutical categories are:

1. Anti-cancer 2. Antibiotics & Anti-microbials 3. Cardiovascular 4. Psychotropic 5. External Preparations 6. Sterile Opthalmics Preparations 7. Generics & Branded Generics 8. Injectables

It also manufactures sildenafil citrate tablets for male impotency

Achievements:

  • The Government of the India has accorded 'Star Export House' status to the company
  • The Government of India also accredited the company with WHO-GMP Certification since 1982.
  • It has received Federation of Indian Export Organisations (FIEO) Export Award 'Niryat Shree'
  • The company has received Chemexcil Top Export Award
  • It has also received Chemexcil Trishul Award for Consistent Export Performance
  • It has received the Government of Maharashtra's Export Award
  • Ministry of Commerce's Award from the President of India was conferred on the company.
  • 2010
    • BDH Industries won ‘Good Corporate Citizen’ Award by Bombay Chamber of Commerce & Industry 2010
    • BDH Industries won State Pharmaceutical Corporation (SPC) Sri Lanka Merit Award 2010
    • WHO-GMP Certificatation since 1982, renewed WHO-GMP in 2010
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×